The bioinformatic approach identifies <i>PARM1</i> as a new potential prognostic factor in osteosarcoma.

Front Oncol · 2022 · PMC10025378 · PMID 36950314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We performed a pan-cancer expression and prognostic analysis of PARM1 and found that PARM1 showed a trend of low expression in most cancers, and low expression of PARM1 in COAD, KIRC, and LUAD predicted poor prognosis of patients, which also confirmed PARM1 as a poor prognostic factor.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.